Sopharma AD (3JR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sopharma AD (3JR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10140
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブルガリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sopharma AD (Sopharma) develops, manufactures and commercializes medicinal substances and finished dosage forms. The company focuses on the production of pharmaceutical products; substances and preparations; veterinary vaccines; infusion solutions; hemodialysis concentrates; medical disposable products; and injection molded products. It also performs research and development and implementation activities catering to the areas of phytochemistry, chemistry and pharmacy. Its key product portfolio consists of carsil, tempalgin, tabex, tribestan, broncholitin, analgin, nivalin and methylprednisolone. Geographically, the company distributes its products in Poland, Russia, Ukraine, Turkey, Georgia, Serbia, Belarus and other countries. Sopharma is headquartered in Sofia, Bulgaria.

Sopharma AD (3JR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sopharma AD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sopharma AD, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sopharma AD, Pharmaceuticals & Healthcare, Deal Details 10
Acquisition 10
Sopharma Acquires Additional 15.14% Stake In Briz, Medical Products Distributor 10
Rompharma Acquires Additional 9% Stake In Sopharma For US$24.3 Million 11
Sopharma Plans To Sell Extab, Biopharma Company 12
Sopharma To Acquire Additional 50.01% Stake In Bulgarska Roza-Sevtopolis 13
Sopharma AD – Key Competitors 14
Sopharma AD – Key Employees 15
Sopharma AD – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 17
Recent Developments 18
Product News 18
03/08/2017: Achieve Life Sciences and OncoGenex Pharmaceuticals Announce Cytisine Symposium at the Annual Society for Research in Nicotine and Tobacco Conference (“SRNT”) 18
02/20/2018: Achieve Announces Preliminary Data from Cytisine Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study 19
Clinical Trials 20
Nov 14, 2017: Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects 20
Oct 04, 2017: Achieve Announces Advancement of Cytisine Clinical Development Program 21
Aug 16, 2017: Achieve Announces Initiation of Cytisine Clinical Development Program 22
Aug 10, 2017: Achieve Announces FDA Acceptance of the Investigational New Drug Application for Cytisine as a Smoking Cessation Treatment 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Sopharma AD, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sopharma AD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sopharma AD, Deals By Therapy Area, 2012 to YTD 2018 8
Sopharma AD, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sopharma Acquires Additional 15.14% Stake In Briz, Medical Products Distributor 10
Rompharma Acquires Additional 9% Stake In Sopharma For US$24.3 Million 11
Sopharma Plans To Sell Extab, Biopharma Company 12
Sopharma To Acquire Additional 50.01% Stake In Bulgarska Roza-Sevtopolis 13
Sopharma AD, Key Competitors 14
Sopharma AD, Key Employees 15
Sopharma AD, Subsidiaries 16
Sopharma AD, Joint Venture 17

List of Figures
Sopharma AD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sopharma AD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Sopharma AD (3JR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Marico Limited (MARICO):企業の財務・戦略的SWOT分析
    Marico Limited (MARICO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Kracie Holdings Ltd:企業の戦略的SWOT分析
    Kracie Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • K’s Holdings Corporation:企業の戦略・SWOT・財務情報
    K's Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary K's Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Harvard Bioscience Inc (HBIO):企業の財務・戦略的SWOT分析
    Harvard Bioscience Inc (HBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Franklin Resources, Inc.:企業のM&A・事業提携・投資動向
    Franklin Resources, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Franklin Resources, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Heerema International Group Services SA:企業の戦略的SWOT分析
    Heerema International Group Services SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • New England Biolabs Inc:医療機器:M&Aディール及び事業提携情報
    Summary New England Biolabs Inc (NEB) is a life science company that develops recombinant and native enzymes for genomic research. The company offers products such as competent cells, DNA plasmids, protein tools, buffers and strains, and others. It has applications in cloning and synthetic biology, …
  • Emera Inc (EMA):企業の財務・戦略的SWOT分析
    Emera Inc (EMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • TearLab Corp (TEAR):製品パイプライン分析
    Summary TearLab Corp (TearLab) is an ophthalmic device company. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. Its osmolar …
  • Sanofi SA:企業のM&A・事業提携・投資動向
    Sanofi SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sanofi SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • General Electric Co (GE)-エネルギー分野:企業M&A・提携分析
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services from aircraft engines, power generation and oil and gas production equipment to medical imaging, …
  • Uniper SE (UN01):企業の財務・戦略的SWOT分析
    Uniper SE (UN01) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Solaria Energia y Medio Ambiente S.A. (SLR)-エネルギー分野:企業M&A・提携分析
    Summary Solaria Energia y Medio Ambiente, S.A. (Solaria) is a manufacturer and supplier of photovoltaic (PV) modules and cells, and provider of turnkey projects. It designs, manufactures, supplies, and installs PV and thermal solutions for power generation. Its product portfolio includes PV modules …
  • Mitsubishi Corporation:戦略・SWOT・企業財務分析
    Mitsubishi Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Worthington Industries Inc:戦略・SWOT・企業財務分析
    Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cytodyn Inc (CYDY):製薬・医療:M&Aディール及び事業提携情報
    Summary Cytodyn Inc (Cytodyn) is a clinical-stage biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies t for the treatment of Human Immunodeficiency Virus (HIV) infections. The company's products pipeline include PRO 140, Cytofe …
  • Iconic Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Iconic Therapeutics Inc (Iconic Therapeutics) is a biopharmaceutical company that provides translation of scientific insight into breakthrough medicines. The company offers development of tissue factor in inflammation, angiogenesis, and metastasis that led to develop new approach to retinal …
  • Hitachi Zosen Corp (7004):電力:M&Aディール及び事業提携情報
    Summary Hitachi Zosen Corp (Hitz) is an industrial and engineering company. It designs, constructs and operates refuse incineration and recycling facilities, pressure vessels, marine diesel engines, and press machines, and other process machine. The company also provides after-sales servicing and ma …
  • San Leon Energy Plc (SLE):石油・ガス:M&Aディール及び事業提携情報
    Summary San Leon Energy Plc (San Leon) is an oil and gas exploration and production company. It is engaged in acquiring, exploring and developing conventional and shale oil and gas assets across Europe and North Africa. The company holds interests in Durresi Block located in offshore Albania and inc …
  • China National Materials Co Ltd:企業の戦略・SWOT・財務情報
    China National Materials Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China National Materials Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆